Urmia University of Medical Sciences

Iran

Country: Iran

Ownership: Private

Established: 1985-01-01

Employees: -

Market Cap: -

Website: http://www.umsu.ac.ir

Clinical Trials

The Effect of Supplementation With Species of Lactobacillus on Anthropometric Measurements

Not Applicable

Completed

Conditions: Overweight and Obesity

Interventions: Dietary Supplement: Species of Lactobacillus
Dietary Supplement: lactose

First Posted Date: 2015-05-20

Last Posted Date: 2015-05-20

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 72

Registration Number: NCT02448940

Locations: 🇮🇷
sardrood Clinic, Tabriz, Iran, Islamic Republic of

The Effect of Yogurt Enriched With Flaxseed on Cardiovascular Risk Factors in Type 2 Diabetic Patients

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Dietary Supplement: low fat yogurt enriched with flaxseed
Dietary Supplement: low fat yogurt

First Posted Date: 2015-05-06

Last Posted Date: 2015-05-06

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 70

Registration Number: NCT02436369

Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation

Phase 3

Completed

Conditions: Paroxysmal Atrial Fibrillation
Sick Sinus Syndrome

Interventions: Device: HBR
Device: DD

First Posted Date: 2014-12-15

Last Posted Date: 2015-10-21

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 200

Registration Number: NCT02317068

Locations: 🇮🇷
Seyyed-al-Shohada Heart Center, UMSU, Urmia, West-Azerbaijan, Iran, Islamic Republic of

Pomegranate Juice and Metabolic Syndrome

Not Applicable

Completed

Conditions: Metabolic Syndrome

Interventions: Other: pomegranate juice
Other: placebo

First Posted Date: 2014-11-24

Last Posted Date: 2014-11-24

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 30

Registration Number: NCT02298621

Locations: 🇮🇷
Urmia University of Medical Sciences, Urmia, Iran, Islamic Republic of

The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease

Not Applicable

Conditions: Non Alcoholic Fatty Liver Disease

Interventions: Dietary Supplement: β- glucan
Dietary Supplement: Maltodextrin

First Posted Date: 2014-07-01

Last Posted Date: 2014-07-01

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 48

Registration Number: NCT02178839

Locations: 🇮🇷
Shekh-al- rais Clinic, Tabriz, Iran, Islamic Republic of

Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair

Phase 3

Completed

Conditions: Heart Valve Diseases

Interventions: Drug: Atorvastatin

First Posted Date: 2014-03-11

Last Posted Date: 2015-03-04

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 58

Registration Number: NCT02084069

Locations: 🇮🇷
Seyyed-al-Shohada Heart Center, Urmia, West-Azerbaijan, Iran, Islamic Republic of

Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography

Phase 3

Completed

Conditions: Stable Angina
Unstable Angina
Non ST Segment Elevation Myocardial Infarction
Post MI

Interventions: Drug: Vitamin E

First Posted Date: 2014-02-25

Last Posted Date: 2015-06-16

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 284

Registration Number: NCT02070679

Locations: 🇮🇷
Taleghani Hospital, UMSU, Urmia, West-Azerbaijan, Iran, Islamic Republic of
🇮🇷
Seyyed-al-Shohada Heart Center, UMSU, Urmia, West-Azerbaijan, Iran, Islamic Republic of

Resistant Starch, Antioxidant Status and Insulin Resistance

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Dietary Supplement: Hi-maize resistant starch
Dietary Supplement: Maltodextrin

First Posted Date: 2013-11-25

Last Posted Date: 2015-08-18

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 21

Registration Number: NCT01992783

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

Phase 2

Completed

Conditions: Disorder of Urinary Stent

Interventions: Drug: Tolterodine
Drug: Placebo
Drug: Terazosine
Drug: Tolterodine + Terazosin

First Posted Date: 2012-02-09

Last Posted Date: 2015-03-02

Lead Sponsor: Urmia University of Medical Sciences

Target Recruit Count: 104

Registration Number: NCT01530243

Locations: 🇮🇷
Imam Khomeini Hospital, Urmia, Azerbaijan-gharbi, Iran, Islamic Republic of

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy